COVID-19 Cicada Variant (BA.3.2): Symptoms, Spread, Risk and What We Know
COVID-19 Cicada Variant BA.3.2 explained: Know its symptoms, spread, mutations, vaccine protection, severity and what health experts say about the risk.
A COVID-19 variant nicknamed “Cicada” has attracted attention in 2026 because of its unusual genetic profile and re-emergence after remaining relatively quiet for a period.
The scientific name of the strain is BA.3.2, a sublineage of the Omicron family. The word “Cicada” is an informal nickname used in media and scientific discussions; it is not an official WHO variant name.
Scientists and public-health authorities are monitoring BA.3.2 because it contains a large number of mutations, particularly in the spike protein. However, there is currently no evidence that Cicada causes more severe illness than other circulating COVID-19 variants.
What Is the COVID-19 Cicada Variant?
The Cicada variant is SARS-CoV-2 BA.3.2, which belongs to the broader Omicron lineage.
BA.3.2 was first identified in South Africa in November 2024. It subsequently remained relatively uncommon before being detected again in different countries.
By February 2026, BA.3.2 had been reported in at least 23 countries, according to scientific surveillance reports.
The nickname “Cicada” refers to the way the lineage appeared to remain relatively quiet before resurfacing, similar to the insect's distinctive life cycle.
Why Is It Called the “Cicada” Variant?
The name is based on the behaviour of the variant rather than its origin.
Cicada insects can remain underground for extended periods before emerging. Similarly, BA.3.2 was identified in 2024 but later became more noticeable after a period of limited detection.
Importantly, the COVID-19 variant does not come from cicadas or insects. Claims suggesting that the virus originated from the insect are false.
How Many Mutations Does BA.3.2 Have?
One of the main reasons scientists are monitoring BA.3.2 is its extensive genetic changes.
The variant has approximately 70–75 substitutions and deletions in its spike protein compared with some commonly referenced earlier SARS-CoV-2 lineages.
The spike protein is particularly important because it is involved in how the virus enters human cells and is also a major target of the immune response.
A high number of mutations does not automatically mean that a virus is more dangerous. Scientists need laboratory, epidemiological and clinical evidence to determine what those mutations mean in real-world infections.
What Are the Symptoms of the Cicada Variant?
Current information suggests that symptoms associated with BA.3.2 are broadly similar to symptoms seen with other COVID-19 infections.
Possible symptoms can include:
- Fever or chills
- Cough
- Sore throat
- Runny or blocked nose
- Fatigue
- Headache
- Shortness of breath
- Loss of taste or smell
- Muscle or body aches
- Nausea, vomiting or diarrhoea in some cases
However, symptoms alone cannot identify BA.3.2. A laboratory test is required to determine the specific viral lineage.
Health information from medical institutions also notes that the available data remain limited for identifying symptoms that are unique to Cicada.
Is Cicada More Dangerous Than Other COVID Variants?
At present, there is no convincing evidence that BA.3.2 causes more severe disease than other currently circulating COVID-19 strains.
The Global Virus Network has said that early evidence shows immune-escape characteristics consistent with Omicron evolution, but there is no evidence of increased severity or widespread transmission that would justify alarm.
BA.3.2 is therefore being monitored rather than treated as a new highly dangerous variant.
Can Cicada Evade Immunity?
This is one of the main scientific questions surrounding BA.3.2.
The large number of spike mutations could allow the variant to partially evade antibodies produced by previous infection or vaccination.
Laboratory studies have found evidence of reduced neutralisation against BA.3.2 in some experimental settings. However, reduced antibody neutralisation does not automatically mean vaccines stop working.
Current evidence continues to indicate that COVID-19 vaccination remains important for protection against serious outcomes.
Does the COVID Vaccine Still Work Against Cicada?
There is no evidence that existing COVID-19 vaccines suddenly become useless against BA.3.2.
The immune response generated by vaccination includes more than one component, and protection against severe disease can remain even when a virus partially escapes antibody responses.
Scientific reviews currently indicate that vaccines are still expected to provide protection against severe disease, hospitalisation and death, although the exact level of protection against infection may vary.
Is Cicada Variant Spreading in India?
BA.3.2 has attracted attention in India as part of wider surveillance of COVID-19 variants.
A July 2026 report from Andhra Pradesh noted that health officials were investigating which variants were contributing to recent COVID-19 cases and mentioned BA.3.2/Cicada alongside XFG and NB.1.8.1 as possible circulating variants.
However, it is important not to claim that every current COVID-19 case in India is caused by Cicada.
Variant surveillance data can change as sequencing information becomes available.
Is Another COVID Wave Coming?
The emergence of BA.3.2 does not automatically mean that another pandemic or lockdown is coming.
Experts have been monitoring the variant because of its mutations and potential immune-evasion characteristics, but current evidence does not indicate that Cicada is causing a new severe global wave.
The situation can change as more surveillance and clinical data become available, which is why public-health authorities continue genomic monitoring.
Should People Be Worried About the Cicada Variant?
For most people, there is no reason to panic simply because BA.3.2 is being called the “Cicada variant.”
The nickname can make the strain sound more mysterious or dangerous than the scientific evidence currently supports.
The important facts are:
- BA.3.2 is a SARS-CoV-2 Omicron sublineage.
- “Cicada” is an informal nickname.
- It has a large number of mutations.
- It is being monitored internationally.
- It may have some immune-evasion characteristics.
- There is currently no evidence that it causes more severe disease.
- Vaccines remain important for protection against severe COVID-19.
How Can People Protect Themselves?
The same basic precautions used for other respiratory infections remain useful.
People can reduce their risk by:
- Staying home when seriously unwell.
- Improving ventilation in crowded indoor spaces.
- Following local public-health advice.
- Keeping COVID vaccinations up to date when recommended.
- Testing when symptoms or exposure make testing appropriate.
- Seeking medical attention for serious symptoms.
People at higher risk of severe COVID-19 should follow advice from their healthcare professionals.
Cicada Variant vs Other COVID Variants
| Feature | Cicada / BA.3.2 |
|---|---|
| Scientific name | BA.3.2 |
| Virus | SARS-CoV-2 |
| Family | Omicron |
| Nickname | Cicada |
| First identified | South Africa, November 2024 |
| Main concern | Extensive spike mutations |
| Immune escape | Evidence of potential immune evasion |
| More severe disease | No evidence currently established |
| Vaccine protection | Still expected to protect against severe outcomes |
| Official WHO name | No — “Cicada” is informal |
Final Words
The COVID-19 Cicada Variant, scientifically known as BA.3.2, is being monitored because of its unusual genetic profile and ability to partially evade some immune responses.
But it is important to separate scientific facts from social-media claims. Cicada is not a new insect-borne virus, and there is currently no evidence that it causes more severe COVID-19 than other variants.
Scientists will continue monitoring its spread, mutations and clinical impact. For now, people should follow reliable health guidance rather than panic over the “Cicada” nickname.
FAQs
What is the Cicada COVID variant?
Cicada is the informal nickname for SARS-CoV-2 BA.3.2, an Omicron sublineage.
Is Cicada an official WHO variant name?
No. Cicada is an informal nickname. BA.3.2 is the scientific lineage designation.
What are the symptoms of BA.3.2?
Symptoms can include fever, cough, sore throat, congestion, fatigue, headache and other symptoms commonly associated with COVID-19. There is currently no confirmed symptom that uniquely identifies BA.3.2.
Is the Cicada variant dangerous?
Current evidence does not show that BA.3.2 causes more severe disease than other circulating COVID-19 variants.
Can Cicada escape vaccines?
BA.3.2 has mutations that may affect antibody recognition, but current evidence does not show that vaccines stop protecting against severe COVID-19 outcomes.
Is Cicada spreading in India?
BA.3.2 has been discussed in Indian COVID-19 surveillance reports, including a July report from Andhra Pradesh, but the exact prevalence can change as genomic sequencing data are updated.
Is another COVID lockdown coming because of Cicada?
There is currently no evidence that the Cicada variant alone means a new lockdown is coming. The variant is being monitored for its spread and clinical impact.
Why is it called Cicada?
The nickname refers to the variant's apparent pattern of remaining relatively quiet before being detected again, similar to the emergence pattern associated with cicadas.